Claiborne Cary J
Insider CIK 1370930 · SCMP Chief financial officer · ADIL Chief Operating Officer, Director · LADX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADIL ADIAL PHARMACEUTICALS, INC | A Award | 2026-04-07 | 2026-04-09 | 37,985 | — | $0 | 40,417 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2025-05-29 | 2025-06-02 | 138,000 | — | $0 | 138,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2024-12-05 | 2024-12-05 | 350,000 | — | $0 | 350,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2024-03-25 | 2024-03-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| LADX LadRx Corp | A Award deriv | 2024-01-15 | 2024-01-29 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2023-05-23 | 2023-05-25 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award | 2023-05-23 | 2023-05-25 | 420,000 | — | $0 | 1,520,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award | 2022-09-20 | 2022-09-20 | 75,000 | $0.42 | $31.5K | 1,100,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award | 2022-09-19 | 2022-09-20 | 25,000 | $0.43 | $10.8K | 1,025,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award | 2022-08-18 | 2022-08-22 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2022-02-23 | 2022-02-25 | 6,667 | — | $0 | 6,667 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2021-12-07 | 2021-12-08 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ADIL ADIAL PHARMACEUTICALS, INC | A Award deriv | 2021-11-02 | 2021-11-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise deriv | 2014-12-16 | 2014-12-17 | 42,900 | — | $0 | 99,987 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise | 2014-12-16 | 2014-12-17 | 42,900 | $4.07 | $174.6K | 45,764 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2014-12-16 | 2014-12-17 | 42,900 | $12.91 | $553.8K | 2,864 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise deriv | 2014-12-15 | 2014-12-17 | 7,100 | — | $0 | 142,887 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise | 2014-12-15 | 2014-12-17 | 7,100 | $4.07 | $28.9K | 9,964 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2014-12-15 | 2014-12-17 | 7,100 | $12.89 | $91.5K | 2,864 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2014-09-11 | 2014-09-15 | 22,027 | — | $0 | 124,987 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2014-09-11 | 2014-09-15 | 25,000 | — | $0 | 149,987 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2014-06-30 | 2014-07-10 | 267 | $6.56 | $1.8K | 2,621 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2014-03-31 | 2014-07-10 | 220 | $6.79 | $1.5K | 2,354 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise deriv | 2014-02-27 | 2014-02-28 | 2,500 | — | $0 | 102,960 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2014-02-27 | 2014-02-28 | 110 | $9.06 | $997 | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2014-02-27 | 2014-02-28 | 2,390 | $9.00 | $21.5K | 110 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise | 2014-02-27 | 2014-02-28 | 2,500 | $4.07 | $10.2K | 2,500 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise deriv | 2014-01-07 | 2014-01-09 | 100 | — | $0 | 105,460 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise deriv | 2014-01-07 | 2014-01-09 | 2,400 | — | $0 | 105,560 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise | 2014-01-07 | 2014-01-09 | 100 | $4.07 | $407 | 2,500 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise | 2014-01-07 | 2014-01-09 | 2,400 | $4.41 | $10.6K | 2,400 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2014-01-07 | 2014-01-09 | 2,500 | $9.00 | $22.5K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2013-12-31 | 2014-01-06 | 196 | $8.93 | $1.8K | 2,134 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | X Exercise deriv | 2013-11-25 | 2013-11-26 | 12,940 | $7.64 | $98.9K | 109,947 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | X Exercise deriv | 2013-11-25 | 2013-11-26 | 49 | $7.64 | $374 | 109,898 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | X Exercise | 2013-11-25 | 2013-11-26 | 12,989 | $7.64 | $99.2K | 109,898 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | X Exercise deriv | 2013-11-22 | 2013-11-26 | 3,511 | $7.46 | $26.2K | 122,887 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | X Exercise | 2013-11-22 | 2013-11-26 | 3,511 | $7.46 | $26.2K | 122,887 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2013-09-30 | 2013-10-01 | 253 | $5.93 | $1.5K | 1,938 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2013-06-28 | 2013-07-02 | 280 | $6.25 | $1.8K | 1,685 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | X Exercise deriv | 2013-05-24 | 2013-05-29 | 2,000 | $9.00 | $18.0K | 125,865 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | X Exercise deriv | 2013-05-24 | 2013-05-29 | 8,300 | $9.00 | $74.7K | 127,865 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | X Exercise | 2013-05-24 | 2013-05-29 | 10,300 | $9.00 | $92.7K | 125,865 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2013-05-21 | 2013-05-22 | 2,400 | $9.55 | $22.9K | 136,165 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2013-05-20 | 2013-05-22 | 2,240 | $9.50 | $21.3K | 138,565 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2013-03-28 | 2013-04-05 | 242 | $6.21 | $1.5K | 1,405 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2012-12-31 | 2013-01-04 | 376 | $4.66 | $1.8K | 1,163 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2012-09-28 | 2012-10-02 | 313 | $4.78 | $1.5K | 787 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2012-06-29 | 2012-07-20 | 263 | $6.68 | $1.8K | 474 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2012-03-30 | 2012-04-06 | 211 | $7.08 | $1.5K | 211 | SEC↗ |